Search
for
Sort by
Research 151–180 of 179
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Wharton’s jelly-derived mesenchymal stem cells in the treatment of four patients with alopecia areata
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Evaluation of Anthropometric Measurements, Arterial Stiffness and ECG Parameters in Alopecia Areata Patients
- Baricitinib for the Treatment of Alopecia Areata
- Alopecia Areata: An Updated Review for 2023
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Alopecia areata: current concepts
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- Altered hypothalamus functional connectivity and psychological stress in patients with alopecia areata
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Prescribing patterns amongst UK dermatologists for the treatment of alopecia areata, female pattern hair loss, and frontal fibrosing alopecia
- Cosmeceutical and Dermatological Potential of Olive Mill Wastewater: A Sustainable and Eco-Friendly Source of Natural Ingredients
- 260 Anti-OX40 monoclonal antibody IMG-007 exhibited clinical activity of hair regrowth, suppressed scalp inflammatory biomarkers in patients with severe alopecia areata in a Ph1b/2a study
- 1368 Effects of phototherapy on refractory alopecia areata
- Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting JAK Inhibitor‐Naïve and JAK Inhibitor‐Experienced Patients
- Ivarmacitinib stimulates hair regrowth in severe alopecia areata
- Photostability and toxicity of finasteride, diclofenac and naproxen under simulating sunlight exposure: evaluation of the toxicity trend and of the packaging photoprotection
- 84 Partial restoration of scalp microbiota in alopecia areata with JAK inhibitors
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- Alopecia areata: Ritlecitinib generates substantial re-growth of scalp hair
- Quality of life in children and adolescents with alopecia areata—A systematic review
- Efficacy and predictive markers of response to tofacitinib and baricitinib therapy in alopecia areata: A 52-week comparative cohort study